Table 1. Profiles of patients and CD24 expression among MS patients with different genotypes.
| Mean fluorescence*
|
|||||||
|---|---|---|---|---|---|---|---|
| ID no. | Sex | Age, yr | EDSS | CD24 | MS type | PBL | T cells |
| Exp. 1 | |||||||
| 8a | F | 60 | 7.0 | a/a | SP | 137 | 27 |
| 11z | M | 64 | 6.5 | a/a | SP | 85 | 34 |
| 15z | F | 24 | 2.0 | a/a | RR | 148 | 22 |
| 32a | F | 62 | 2.0 | a/a | RR | 201 | 29 |
| 76z | F | 57 | 6.5 | a/a | SP | 143 | 83 |
| 25a | F | 51 | 6.0 | v/v | RR | 225 | 210 |
| 27a | F | 50 | 2.0 | v/v | RR | 351 | 545 |
| 7y | F | 47 | 2.0 | v/v | RR | 58 | 51 |
| 118z | M | 70 | 7.0 | v/v | SP | 117 | 148 |
| 122z | F | 66 | 7.0 | v/v | SP | 283 | 302 |
| Exp. 2 | |||||||
| 42z | F | 56 | 6.0 | a/a | SP | 71 | 35 |
| 43z | F | 43 | 2.0 | a/a | RR | 264 | 65 |
| 45z | F | 54 | 2.0 | a/a | RR | 56 | 20 |
| 46z | M | 61 | 7.5 | a/a | PP | 69 | 30 |
| 48z | M | 64 | 6.0 | a/a | PP | 180 | 66 |
| 12y | F | 59 | 6.5 | a/a | SP | 49 | 37 |
| 44z | F | 54 | 2.0 | a/v | RR | 204 | 92 |
| 47z | F | 33 | 2.0 | a/v | RR | 110 | 60 |
| 11y | F | 67 | 2.0 | a/v | RR | 158 | 52 |
| 21a | F | 51 | 5.0 | a/v | RR | 125 | 30 |
| 22a | M | 61 | 7.5 | a/v | SP | 185 | 92 |
| 23a | F | 59 | 2.5 | a/v | RR | 88 | 72 |
RR, remitting relapsing; SP, secondary progressive; PP, primary progressive; F, female; M, male.
*
Samples from RR patients were collected during the remitting phase